Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

BACKGROUND: HVTN 505 was a human immunodeficiency virus type 1 (HIV-1) preventive vaccine efficacy trial of a DNA/recombinant adenovirus serotype 5 (rAd5) vaccine regimen. We assessed antibody responses measured 1 month after final vaccination (month 7) as correlates of HIV-1 acquisition risk. METHO...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Fong, Youyi, Shen, Xiaoying, Ashley, Vicki C, Deal, Aaron, Seaton, Kelly E, Yu, Chenchen, Grant, Shannon P, Ferrari, Guido, deCamp, Allan C, Bailer, Robert T, Koup, Richard A, Montefiori, David, Haynes, Barton F, Sarzotti-Kelsoe, Marcella, Graham, Barney S, Carpp, Lindsay N, Hammer, Scott M, Sobieszczyk, Magda, Karuna, Shelly, Swann, Edith, DeJesus, Edwin, Mulligan, Mark, Frank, Ian, Buchbinder, Susan, Novak, Richard M, McElrath, M Juliana, Kalams, Spyros, Keefer, Michael, Frahm, Nicole A, Janes, Holly E, Gilbert, Peter B, Tomaras, Georgia D
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018910/
https://ncbi.nlm.nih.gov/pubmed/29325070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados